B

Boundless Bio Inc
NASDAQ:BOLD

Watchlist Manager
Boundless Bio Inc
NASDAQ:BOLD
Watchlist
Price: 3.24 USD -9.24% Market Closed
Market Cap: 72.1m USD
Have any thoughts about
Boundless Bio Inc?
Write Note

Boundless Bio Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Boundless Bio Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Boundless Bio Inc
NASDAQ:BOLD
Cash from Financing Activities
$97.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Boundless Bio Inc's Cash from Financing Activities?
Cash from Financing Activities
97.9m USD

Based on the financial report for Dec 31, 2023, Boundless Bio Inc's Cash from Financing Activities amounts to 97.9m USD.

What is Boundless Bio Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
77 596%

Over the last year, the Cash from Financing Activities growth was 77 596%.

Back to Top